Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul Rothman currently holds 1,670 shares of LABORATORY CORP OF AMERICA HOLDINGS (LH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Rothman has been a net neutral trader of LH stock. They have purchased $0 and sold $0 worth of shares.
Paul Rothman's most recent insider trade was on Feb 10, 2026, when they sold 733 shares at $0.00 per share.
Paul Rothman serves as Executive at LABORATORY CORP OF AMERICA HOLDINGS (LH). They have executed 6 insider transactions totaling $0 over their tenure at the company.
Paul Rothman holds the position of Executive at LABORATORY CORP OF AMERICA HOLDINGS, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Paul Rothman has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Paul Rothman was on May 31, 2024, when they purchased $220.0K worth of MRK shares. This transaction involved 1,752.43 shares at $125.54 per share.
Paul Rothman currently owns 1,670 shares of LABORATORY CORP OF AMERICA HOLDINGS (LH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul Rothman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul Rothman has 6 Form 4 filings on record as an insider at LABORATORY CORP OF AMERICA HOLDINGS.
Set alerts for Paul Rothman and 40,000+ other insiders.